PMID: 3763138Jul 1, 1986Paper

The use of clonazepam in the treatment of nystagmus-induced oscillopsia

Ophthalmology
J N Currie, V Matsuo

Abstract

The effect of clonazepam was studied in ten patients with nystagmus-induced oscillopsia due to downbeating or other primary position nystagmus. A 1-2-mg single-dose clonazepam test was used to determine whether long-term clonazepam therapy was indicated and to help distinguish between visual loss from underlying retinal or optic nerve disease and visual loss due to the nystagmus itself. With the single-dose clonazepam test, nystagmus was eliminated in 6 of 10 patients in the primary position of gaze and in 7 of 10 patients in downgaze. In all positions of gaze in all patients there was significant reduction in nystagmus intensity and slow phase velocity. Symptoms of oscillopsia were reduced or eliminated in all patients, and 7 of 8 patients with reduced visual acuity had clinical improvement. Guidelines are presented for the use of clonazepam in a single-dose clonazepam test and for long-term therapy.

References

Nov 1, 1978·Annals of Neurology·J N Alpert
Jun 1, 1976·Brain : a Journal of Neurology·D S ZeeW K Engel
Mar 1, 1975·Vision Research·H CollewijnT C Jansen
Mar 1, 1974·Archives of Neurology·D S ZeeD A Robinson
May 1, 1974·Journal of Neurology, Neurosurgery, and Psychiatry·J C AschoffH H Kornhuber
Dec 1, 1968·Archives of Ophthalmology·D G Cogan
Dec 1, 1984·Archives of Neurology·N L Zasorin, R W Baloh
Feb 1, 1983·Annals of Neurology·B R ChambersM A Gresty
Jun 1, 1983·Annals of Neurology·P J LavinC Ellenberger
Mar 1, 1981·Neurology·R W Baloh, J W Spooner
May 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·M A GrestyL J Findley
Dec 1, 1980·Annals of Neurology·G M HalmagyiD S Zee
Oct 1, 1981·Archives of Neurology·R F Saul, J B Selhorst
Aug 1, 1965·Archives of Neurology·M B BENDER
Jun 1, 1983·Annals of Neurology·L A AbelC F Ansevin

❮ Previous
Next ❯

Citations

Jul 18, 2008·Der Nervenarzt·R KallaM Strupp
Jan 22, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C Pieh-Beisse, W A Lagrèze
Apr 5, 2011·Journal of Neurology·Michael StruppR John Leigh
Nov 11, 2011·Current Treatment Options in Neurology·Matthew J Thurtell, R John Leigh
Nov 30, 2000·Current Treatment Options in Neurology·L Averbuch-Heller
Jul 27, 2001·Neurologic Clinics·T Z MovsasN J Volpe
Sep 25, 2001·The Laryngoscope·Y H Young, T W Huang
Nov 29, 2001·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·J I KimR J Leigh
Nov 26, 2010·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Matthew J Thurtell, R John Leigh
Sep 13, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A StraubeUNKNOWN European Federation of Neurologic Societies
Apr 19, 2002·Annals of the New York Academy of Sciences·R John LeighScott H Seidman
Dec 3, 2014·Neurologic Clinics·Shin C BehElliot M Frohman
Jan 18, 2006·Current Opinion in Neurology·Michael Strupp, Thomas Brandt
Feb 5, 2016·Expert Review of Ophthalmology·Aasef G Shaikh, Fatema F Ghasia
Aug 1, 1996·Ophthalmology·A J Flach
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Rebecca Jane McLean, Irene Gottlob
Jul 1, 2009·Therapeutic Advances in Neurological Disorders·Michael Strupp, Thomas Brandt
Jan 30, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A StraubeD Straumann
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Andreas Straube
Feb 23, 2019·Current Treatment Options in Neurology·Christopher D StephenJeremy D Schmahmann
Mar 24, 1998·The Journal of Laryngology and Otology·L M Luxon
Jun 17, 2009·Expert Opinion on Pharmacotherapy·Thomas BrandtMichael Strupp
May 1, 1990·Acta Neurologica Scandinavica·H W McConnellM W Mair
Aug 27, 2021·Journal of Neurology·Eun Hye OhJae-Hwan Choi
Aug 31, 2021·Current Opinion in Ophthalmology·Tu M TranCollin M McClelland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.